| Open Label Study to Compare Efficacy, Safety and Tolerability of Hydroxychloroquine Combined With Azithromycin Compared to Hydroxychloroquine Combined With Camostat Mesylate and to "no Treatment" in SARS CoV 2 Virus (NCT04355052) | Sheba Medical Center | 2020-04-11 |
| Study of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients: Sarilumab, Azithromycin, Hydroxychloroquine Trial - CORIMUNO-19 - VIRO (NCT04341870) | Assistance Publique - Hôpitaux de Paris | 2020-04-11 |
| The Fleming [FMTVDM] Directed CoVid-19 Treatment Protocol (NCT04349410) | The Camelot Foundation | 2020-04-11 |
| Polyvalent Immunoglobulin in COVID-19 Related ARds (NCT04350580) | Centre Hospitalier St Anne | 2020-04-11 |
| Hydroxychloroquine Plus Azithromycin Versus Hydroxychloroquine for COVID-19 Pneumonia (COVIDOC Trial) (NCT04345861) | University Hospital, Montpellier | 2020-04-11 |
| Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Subjects With Severe Coronavirus Disease 2019 (COVID-19) (NCT04341116) | I-Mab Biopharma US Limited | 2020-04-11 |
| Clearing the Fog: Is Hydroxychloroquine Effective in Reducing COVID-19 Progression (NCT04491994) | UNICEF | 2020-04-10 |
| A Study of Ixekizumab (LY2439821) in Chinese Participants With Radiographic Axial Spondyloarthritis (NCT04285229) | Eli Lilly and Company | 2020-04-10 |
| ACE Inhibitors or ARBs Discontinuation in Context of COVID-19 Pandemic (NCT04329195) | Assistance Publique - Hôpitaux de Paris | 2020-04-09 |
| Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to the Usual Radiation Treatment for Newly Diagnosed Early Stage High Intermediate Risk Endometrial Cancer (NCT04214067) | National Cancer Institute (NCI) | 2020-04-09 |
| A Study of Bevacizumab, Carboplatin, and Paclitaxel or Pemetrexed With or Without Atezolizumab in Chemotherapy-Naïve Patients With Stage IV Non-Squamous Non-Small Cell Lung Cancer (IMpower151) (NCT04194203) | Hoffmann-La Roche | 2020-04-09 |
| A Study of the Effectiveness of an Off Label Mefloquine Use for the Treatment of Patients With COVID19 (NCT04347031) | Burnasyan Federal Medical Biophysical Center | 2020-04-08 |
| Convalescent Plasma as Therapy for Covid-19 Severe SARS-CoV-2 Disease (CONCOVID Study) (NCT04342182) | Erasmus Medical Center | 2020-04-08 |
| A Phase III Transition Study of DRL Rituximab to Reference Medicinal Products (NCT04268771) | Dr. Reddy's Laboratories Limited | 2020-04-08 |
| An Open Randomized Study of Dalargin Efectiveness in Combination With Leitragin Drug in Patients With Severe and Critical Manifestations of SARS-COVID-19 (NCT04346693) | Burnasyan Federal Medical Biophysical Center | 2020-04-08 |
| Study of Efficacy and Safety of Ligelizumab in Chronic Spontaneous Urticaria Patients Who Completed a Previous Study With Ligelizumab (NCT04210843) | Novartis Pharmaceuticals | 2020-04-08 |
| COVID19-Convalescent Plasma for Treating Patients With Active Symptomatic COVID 19 Infection (FALP-COVID) (NCT04384588) | Fundacion Arturo Lopez Perez | 2020-04-07 |
| A Study to Assess Recurrence of Actinic Keratosis in Participants Treated With Methyl Aminolevulinate Hydrochloride Cream or Vehicle Cream Who Achieved Complete Response to Treated Lesions in Earlier Study (NCT04269395) | Galderma R&D | 2020-04-07 |
| Tocilizumab for the Treatment of Cytokine Release Syndrome in Patients With COVID-19 (SARS-CoV-2 Infection) (NCT04361552) | Emory University | 2020-04-07 |
| Will Hydroxychloroquine Impede or Prevent COVID-19 (NCT04341441) | Henry Ford Health System | 2020-04-07 |
| Multi-site Adaptive Trials for COVID-19 (NCT04370262) | Northwell Health | 2020-04-07 |
| Phase III Study of Toripalimab Versus Placebo Plus Chemotherapy in Resectable NSCLC (NCT04158440) | Shanghai Junshi Bioscience Co., Ltd. | 2020-04-07 |
| Pre-exposure Prophylaxis for SARS-Coronavirus-2 (NCT04328467) | University of Minnesota | 2020-04-06 |
| Comparison of Anti-microbial Efficacy of Calcipex and Metapex in Endodontic Treatment of Chronic Apical Periodontitis (NCT04336709) | Aga Khan University | 2020-04-06 |
| Evaluating Newly Approved Drugs in Combination Regimens for Multidrug-Resistant TB With Fluoroquinolone Resistance (endTB-Q) (NCT03896685) | Médecins Sans Frontières, France | 2020-04-06 |
| COVID MED Trial - Comparison Of Therapeutics for Hospitalized Patients Infected With COVID-19 (NCT04328012) | Bassett Healthcare | 2020-04-06 |
| Mesenchymal Stem Cell Therapy for SARS-CoV-2-related Acute Respiratory Distress Syndrome (NCT04366063) | Royan Institute | 2020-04-05 |
| Clinical Trial to Evaluate the Efficacy of Different Treatments in Patients With COVID-19 (NCT04890626) | Instituto de Investigación Hospital Universitario La Paz | 2020-04-04 |
| Hydroxychloroquine,Hydroxychloroquine,Azithromycin in the Treatment of SARS CoV-2 Infection (NCT04341727) | Washington University School of Medicine | 2020-04-04 |
| Evaluation of Efficacy of Levamisole and Formoterol+Budesonide in Treatment of COVID-19 (NCT04331470) | Fasa University of Medical Sciences | 2020-04-04 |
| Pyridostigmine in Severe SARS-CoV-2 Infection (NCT04343963) | Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | 2020-04-04 |
| Pre-Exposure Prophylaxis With Hydroxychloroquine for High-Risk Healthcare Workers During the COVID-19 Pandemic (NCT04331834) | Barcelona Institute for Global Health | 2020-04-03 |
| Treatment of COVID-19 Patients With Anti-interleukin Drugs (NCT04330638) | University Hospital, Ghent | 2020-04-03 |
| Evaluation of the Pharmacokinetics and Pharmacodynamics of Hydroxychloroquine in COVID-19 Intensive Care Unit Patients (NCT04522466) | Centre Hospitalier Universitaire de Saint Etienne | 2020-04-03 |
| A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia (NCT04320615) | Hoffmann-La Roche | 2020-04-03 |
| COmbination Therapy With Baloxavir and Oseltamivir 1 for Hospitalized Patients With Influenza (The COMBO Trial 1) (NCT04327791) | Bassett Healthcare | 2020-04-03 |
| Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic Disease (NCT04332991) | Massachusetts General Hospital | 2020-04-02 |
| Hydroxychloroquine vs. Azithromycin for Outpatients in Utah With COVID-19 (NCT04334382) | Intermountain Health Care, Inc. | 2020-04-02 |
| Study of Single Agent Belantamab Mafodotin Versus Pomalidomide Plus Low-dose Dexamethasone (Pom/Dex) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) (NCT04162210) | GlaxoSmithKline | 2020-04-02 |
| K-924 Phase III Confirmatory Study (NCT04289649) | Kowa Company, Ltd. | 2020-04-02 |
| Efficacy and Safety of Emapalumab and Anakinra in Reducing Hyperinflammation and Respiratory Distress in Patients With COVID-19 Infection. (NCT04324021) | Swedish Orphan Biovitrum | 2020-04-02 |
| Assessment of the Clinical Effectiveness of a Herbal Extract (Cretan IAMA) in Patients With Viral Respiratory Infections, Including COVID-19, in Primary Healthcare Settings, and Co-assessment of Its Prophylactic Effect in People Cohabiting With These Patients (NCT04705753) | University of Crete | 2020-04-01 |
| Efficacy of Azithromycin-associated Hydroxychloroquine Therapy Given in General Practice in Early-stage Disease in COVID-19 Patients (NCT04371406) | Assistance Publique - Hôpitaux de Paris | 2020-04-01 |
| Hydroxychloroquine Versus Placebo in COVID-19 Patients at Risk for Severe Disease (NCT04325893) | University Hospital, Angers | 2020-04-01 |
| Efficacy and Safety of Dapagliflozin in Acute Heart Failure (NCT04298229) | Vanderbilt University Medical Center | 2020-04-01 |
| Suprachoroidal Triamcinolone Acetonide in Harada's Retinal Detachment (NCT05031143) | Benha University | 2020-04-01 |
| Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-Cov-2 Virus (COVID-19) (NCT04322123) | Hospital do Coracao | 2020-04-01 |
| Seasonal Malaria Vaccination (RTS,S/AS01) and Seasonal Malaria Chemoprevention (SP/AQ) Extension Study (NCT04319380) | London School of Hygiene and Tropical Medicine | 2020-04-01 |
| HCQ for Primary Prophylaxis Against COVID19 in Health-care Workers (NCT04336748) | Medical University of Vienna | 2020-04-01 |
| mFOLFOXIRI Versus mFOLFOX6 as Adjuvant Chemotherapy for Locally Advanced Colorectal Cancer (NCT04338191) | Sun Yat-sen University | 2020-04-01 |
| As-needed Budesonide/Formoterol Turbuhaler in Stepping Down Period (NCT04215848) | Hat Yai Medical Education Center | 2020-04-01 |
| Cefalium® Compared to Tylenol® in the Treatment of Migraine Attacks (NCT02582996) | Ache Laboratorios Farmaceuticos S.A. | 2020-04-01 |
| Hydroxychloroquine Azithromycin COVID-19 Pregnancy Trial (NCT04365231) | Hospital St. Joseph, Marseille, France | 2020-04-01 |
| Lanreotide Combined With Telotristat Ethyl or Placebo for the First-line Treatment in Patients With Advanced Well Differentiated Small Intestinal Neuroendocrine Tumours (siNET) With Highly-functioning Carcinoid Syndrome (NCT04065165) | European Organisation for Research and Treatment of Cancer - EORTC | 2020-04-01 |
| Phase III Clinical Study of Azvudine in Hiv-infected Treatment Naive Patients (NCT04303598) | Henan Genuine Biotech Co., Ltd. | 2020-04-01 |
| The Efficacy and Safety of Huai er in the Adjuvant Treatment of COVID-19 (NCT04291053) | Tongji Hospital | 2020-04-01 |
| The Benefit of Add On DLBS1033 for Ischemic Stroke Patient (NCT04425590) | Duta Wacana Christian University | 2020-04-01 |
| The Value of Palliative Primary Tumor Resection in Metastatic Colon Cancer (NCT04416854) | Fudan University | 2020-04-01 |
| Role of Triptorelin 0.1 mg as a Luteal Phase Support in Assisted Reproductive Technique After Embryo Transfer : a Randomized Controlled Trial (NCT04087408) | Moustafa Mohammed Abouelea | 2020-04-01 |
| Clinical Trial to Evaluate Methylprednisolone Pulses and Tacrolimus in Patients With COVID-19 Lung Injury (NCT04341038) | Hospital Universitari de Bellvitge | 2020-04-01 |
| Vaginal Progesterone for the Prevention of Preterm Birth in Twins (NCT03540225) | Chiu Yee Liona Poon | 2020-04-01 |
| Safety And Efficacy Of Hydroxychloroquine For At Risk Population (SHARP) Against COVID-19 (NCT04342156) | Tan Tock Seng Hospital | 2020-04-01 |
| Hydroxychloroquine as Post Exposure Prophylaxis for SARS-CoV-2(HOPE Trial) (NCT04330144) | Gangnam Severance Hospital | 2020-04-01 |
| Evaluation of Efficacy of TOOKAD® (VTP) Versus Active Surveillance for Intermediate Risk Localized Prostate Cancer (NCT04225299) | Steba Biotech S.A. | 2020-03-31 |
| To Compare ZOLADEX 10.8 mg With ZOLADEX 3.6mg in Chinese Pre-menopausal ER+ HER2- Early Breast Cancer. (NCT03658213) | AstraZeneca | 2020-03-31 |
| Hydroxychloroquine for COVID-19 Post-exposure Prophylaxis (PEP) (NCT04328961) | University of Washington | 2020-03-31 |
| Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate (NCT04136353) | University of Sydney | 2020-03-31 |
| Efficacy of the Infusion of Donor Plasma in COVID-19 Infection (NCT05247307) | Hospital Galdakao-Usansolo | 2020-03-31 |
| Randomized, Controlled Study of IFX-1 in Patients With Severe COVID-19 Pneumonia (NCT04333420) | InflaRx GmbH | 2020-03-31 |
| BCG Vaccination to Protect Healthcare Workers Against COVID-19 (NCT04327206) | Murdoch Childrens Research Institute | 2020-03-30 |
| An Efficacy and Safety Study of Ravulizumab in ALS Participants (NCT04248465) | Alexion Pharmaceuticals, Inc. | 2020-03-30 |
| Safety and Efficacy of the Effect of Isosorbide Mononitrate in Reducing Pain During Levonorgestrel-releasing Intrauterine Device Insertion (NCT04311658) | Cairo University | 2020-03-30 |
| Effect of Oral Tramadol Administration Prior to IUD Insertion (NCT04312061) | Cairo University | 2020-03-30 |
| Acute Effect of Empagliflozin vs Dapagliflozin Over Pulse Wave Velocity in Type Two Diabetes (NCT05109949) | Centro Universitario de Ciencias de la Salud, Mexico | 2020-03-30 |
| Research on Cognitive Effect of Cannabidiol on Dravet Syndrome and Lennox-Gastaut SyndromeGastaut Syndrome (NCT04611438) | Yonsei University | 2020-03-30 |
| Effectiveness and Tolerability of the On-demand Use of Combined Dapoxetine With Tadalafil and Combined Dapoxetine With Lidocaine 5% Spray in Treatment of Patients With Lifelong Premature Ejaculation and Non-responding to Dapoxetine Alone. (NCT04703127) | Sohag University | 2020-03-30 |
| Enfortumab Vedotin and Pembrolizumab vs. Chemotherapy Alone in Untreated Locally Advanced or Metastatic Urothelial Cancer (NCT04223856) | Astellas Pharma Global Development, Inc. | 2020-03-30 |
| Immune Monitoring of Prophylactic Effect of Hydroxychloroquine in Healthcare Providers Highly Exposed to COVID-19 (NCT04346329) | Universidad Nacional de Colombia | 2020-03-30 |
| Hydroxychloroquine for COVID-19 (NCT04342221) | University Hospital Tuebingen | 2020-03-29 |
| Hydroxychloroquine Post Exposure Prophylaxis for Coronavirus Disease (COVID-19) (NCT04318444) | Columbia University | 2020-03-29 |
| Effectiveness of Hydroxychloroquine in Covid-19 Patients (NCT04328272) | Prof. Dr. Umar Farooq | 2020-03-28 |
| Safety and Efficacy of Hydroxychloroquine Associated With Azithromycin in SARS-CoV2 Virus (Coalition Covid-19 Brasil II) (NCT04321278) | Hospital Israelita Albert Einstein | 2020-03-28 |
| Sarilumab COVID-19 (NCT04327388) | Sanofi | 2020-03-28 |
| The Efficacy of Different Anti-viral Drugs in COVID 19 Infected Patients (NCT04321616) | Oslo University Hospital | 2020-03-28 |
| Neoadjuvant mFOLFOXIRI Plus Bevacizumab in Patients With High-Risk Locally Advanced Rectal Cancer (NCT04215731) | Yanhong Deng | 2020-03-27 |
| Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients - Sarilumab Trial - CORIMUNO-19 - SARI (NCT04324073) | Assistance Publique - Hôpitaux de Paris | 2020-03-27 |
| ELUCIDATE: Enabling Lung Cancer Identification Using Folate Receptor Targeting (NCT04241315) | On Target Laboratories, LLC | 2020-03-26 |
| A Study of Oral Venetoclax Tablets and Oral Azacitidine as Maintenance Therapy in Adult Participants With Acute Myeloid Leukemia in First Remission After Conventional Chemotherapy (NCT04102020) | AbbVie | 2020-03-26 |
| Study of Nusinersen (BIIB058) in Participants With Spinal Muscular Atrophy (NCT04089566) | Biogen | 2020-03-26 |
| A Randomized Controlled Clinical Trial: Hydroxychloroquine for the Treatment of COVID-19 in Hospitalized Patients (NCT04345692) | Queen's Medical Center | 2020-03-26 |
| Clinical Study To Evaluate The Performance And Safety Of Favipiravir in COVID-19 (NCT04336904) | Giuliano Rizzardini | 2020-03-25 |
| Reducing Health Care Workers Absenteeism in Covid-19 Pandemic Through BCG Vaccine (NCT04328441) | UMC Utrecht | 2020-03-25 |
| Preemptive Therapy for SARS-Coronavirus-2 (COVID-19 PEP Canada) (NCT04421664) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2020-03-25 |
| Lasmiditan Compared to Placebo in the Acute Treatment of Migraine in Korean (NCT04218162) | IlDong Pharmaceutical Co Ltd | 2020-03-24 |
| Anlotinib Plus Immune Checkpoint Inhibitors for Lung Cancer (NCT04322617) | Hunan Province Tumor Hospital | 2020-03-24 |
| K-924 Phase III Long Term Study (NCT04289662) | Kowa Company, Ltd. | 2020-03-23 |
| Extension to Study on Efficacy and Safety of Linzagolix for the Treatment of Endometriosis-associated Pain (NCT04372121) | Kissei Pharmaceutical Co., Ltd. | 2020-03-23 |
| Efficacay of Chloroquine or Hydroxychloroquine in COVID-19 Treatment (NCT04353336) | Tanta University | 2020-03-23 |
| Escin in Patients With Covid-19 Infection (NCT04322344) | University of Catanzaro | 2020-03-23 |
| Colchicine Coronavirus SARS-CoV2 Trial (COLCORONA) (NCT04322682) | Montreal Heart Institute | 2020-03-23 |